Additional Information

Official title

Safety and Efficacy of Allogeneic Umbilical Cord Blood Therapy for Patients With Stroke

Principal investigator

MinYoung Kim, M.D., Ph.D.

Description

Stroke is one of the most common etiologies causing disability in developed countries. There
remains no proven treatments except tissue plasminogen activator currently. Based on
promising results of cell therapy in animal stroke models, efforts to apply cell therapy for
patients with stroke has been made. UCB possess various stem or progenitor cells and is
known to secrete neurotrophic factors to repair injured brain. This clinical research aims
to determine the safety and efficacy of allogeneic UCB for stroke.

Trial information was received from ClinicalTrials.gov and was last updated in January 2014.